Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
Mystery: Why Would Hand OA Be Less Severe in Black People? Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
Trial Data Confirm Heightened Risks With JAK Inhibitor May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
Psoriasis Patients, Docs Want to Do More to Prevent Heart Problems Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
Don't Expect Much From COVID Vax in This Patient Group With rituximab on board, even third doses didn't induce meaningful antibody response Jan 13, 2022
Muddled Picture for Antidepressant as Osteoarthritis Pain Reliever Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
Biologic Disappoints for Arthritis Achilles' Inflammation But phase III trial did find some patient-oriented benefits Nov 11, 2021
For Systemic JIA, Start Biologics Early Observational study shows excellent efficacy in systemic pediatric arthritis Nov 10, 2021
HAE Still Drawing Attention From Drugmakers Two new products show midstage promise in hereditary angioedema Nov 10, 2021
Secukinumab: An Up-and-Coming Option in Giant Cell Arteritis? Phase II trial found sustained remission with steroid-sparing effects Nov 10, 2021
Avacopan Helps Vasculitis Patients With Renal Impairment Wean Off Steroids Patients saw better eGFR recovery compared with prednisone Nov 08, 2021
Vitamin D and Disease Prevention: Worth Another Look? Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
Guselkumab Response Durable in Psoriatic Arthritis Skin and joint improvements persisted through 2 years of follow-up Nov 08, 2021
Could This Biologic Drug Work in Patients Lacking Its Target? Bizarre finding with omalizumab Nov 07, 2021
Mixed Results With Anti-Interleukin Biologics in Asthma One shows promise; another fails miserably (and mysteriously) Oct 27, 2021
No Love for PRP in Ankle Osteoarthritis Trial Dutch researchers throw cold water on popular therapy Oct 26, 2021
Following Rituximab With Second Biologic Helpful in Lupus Trial may provide answer for patients who don't respond to B-cell depletion Oct 25, 2021
How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
First Interchangeable Humira Biosimilar Approved Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
FDA Gives Thumbs Up to ANCA-Associated Vasculitis Drug Approval granted to avacopan despite advisory committee concerns Oct 08, 2021
Is This the Future of Corticosteroids? Novel agent, aimed at doing away with adverse metabolic effects, proves mettle in DMD Oct 05, 2021
Olfactory Loss Common in Sjogren's Syndrome Objective impairments in olfaction correlated with disease activity and symptoms Sep 29, 2021
IBD and Pediatric Arthritis: Exploring the Link Risk factors include enthesitis, family history, and etanercept use Sep 15, 2021
Pneumocystis Often Lethal in Dermatomyositis Incidence of pneumonia high in MDA5-antibody-positive patients Sep 10, 2021
FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risks Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
What's Causing Cancer Patient's Joint Pain While on Checkpoint Inhibitor? Here is how clinicians diagnosed this rare inflammatory side effect Aug 30, 2021
What Factors Predict RA in First-Degree Relatives? Study may offer insight into preclinical phase to identify factors that predict progression Aug 12, 2021
New-Onset IBD and IL-17 Inhibitors: What Is the Risk? Underlying inflammatory disease severity should be taken into account Jul 21, 2021
FDA Approves IVIG for Dermatomyositis Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
Slow Steroid Tapering Succeeds in SLE Flare rates were significantly lower with gradual withdrawal than with low-dose maintenance Jul 13, 2021
Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
Pain Persists in RA, Even Without Inflammation At 5 years, one-third of patients with rheumatoid arthritis still had "unacceptable" pain Jun 22, 2021
Osteoarthritis: A Link With Parkinson's? Inflammation may contribute to both joint and nerve degeneration Jun 09, 2021
Secukinumab Shows Promise for Kids With Arthritis More than 90% responded at week 12, study showed Jun 07, 2021
Personalized Algorithm Helps Guide Rituximab Retreatment For ANCA-associated vasculitis, fixed retreatment not needed if naive B cells reappear Jun 05, 2021
Nintedanib Slows Decline in RA-Associated Interstitial Lung Disease Similar results to original larger trial seen in post-hoc analysis Jun 04, 2021
Oral JAK 1 Inhibitor Eases Spine Inflammation in Ankylosing Spondylitis Treatment with filgotinib resulted in significant improvements compared with placebo Jun 04, 2021